×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Therapeutic
group
CTD_human
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
26443449
2015
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
BEFREE
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
26443449
2015
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
BEFREE
Expression of Sp1 and c-FLIP are elevated while AKR1C1, ERβ and Sp3 are significantly low in human prostate tumor samples.
25816367
2015
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
BEFREE
An inverse correlation between the expression of ERβ and IKKβ/p65 was also observed in the prostates of ERβ knockout (BERKO) mice, Gleason grade 5 prostate tumors and analysis of prostate cancer databases.
26450901
2015
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
CTD_human
The mRNA levels of PPFIBP2 and ESR2 are differentially expressed in prostate tumours and paired normal tissues.
26443449
2015
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
BEFREE
The objective of this study was to examine serum estrogens and prostate tumor ERβ expression and examine their correlation with clinical and pathological parameters in African American (AA) versus Caucasian American (CA) men.
23658372
2013
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
BEFREE
Our results demonstrate that estrogens and antiestrogens affect prostate tumor growth through ERβ -mediated regulation of KLF5.
21487105
2011
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
GeneticVariation
group
LHGDN
Association between estrogen and androgen receptor genes and prostate cancer risk.
18952763
2009
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
LHGDN
Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells.
18607069
2008
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
GeneticVariation
group
LHGDN
Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
17932344
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
CTD_human
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
17639508
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
LHGDN
BPA dramatically attenuated estrogen receptor beta (ERbeta ) expression; this finding was specific to prostate tumor cells in which BPA induces cellular proliferation.
18007998
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
LHGDN
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
17503469
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
AlteredExpression
group
LHGDN
Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer.
17585029
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Therapeutic
group
CTD_human
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
17639508
2007
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
CTD_human
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
16921512
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
GeneticVariation
group
LHGDN
Estrogen receptor beta polymorphism is associated with prostate cancer risk.
16551880
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Therapeutic
group
CTD_human
Apigenin suppresses cancer cell growth through ERbeta.
17132221
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
CTD_human
Apigenin suppresses cancer cell growth through ERbeta.
17132221
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Therapeutic
group
CTD_human
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
16921512
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
GeneticVariation
group
LHGDN
Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
16921512
2006
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Therapeutic
group
CTD_human
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
16220300
2005
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
CTD_human
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
16220300
2005
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
LHGDN
Thus our findings implicate ERbeta as a potential target for the treatment of prostate tumours .
15171712
2004
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.400
Biomarker
group
BEFREE
Thus our findings implicate ERbeta as a potential target for the treatment of prostate tumours .
15171712
2004